Drug – bio-affecting and body treating compositions – Fermentate of unknown chemical structure – Having a known elemental analysis
Patent
1974-02-14
1976-03-09
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Fermentate of unknown chemical structure
Having a known elemental analysis
260112B, A61K 3514, A61K 3516, C07G 700, C07G 7026
Patent
active
039432459
ABSTRACT:
The purification of plasminogen from human and non-human mammalian plasma or Cohn Fraction III by modified affinity chromotography using Sepharose-L-lysine with high ionic strength buffer solutions as in ion exchange chromatography is described. A plasminogen is produced in great yield having unexpectedly enhanced activity toward N.sup..alpha.-CBZ-L-lysine p-nitrophenyl ester, enhanced fibrinolytic activity and significantly less contamination by unknown colloidal substances.
REFERENCES:
patent: 3234106 (1966-02-01), Hink, Jr.
Brockway et al., J. Biol. Chem., 246, pp. 4641-4647 (1971).
Science, 170, pp. 1095-1096 (1970).
Chemical Abstracts, Vol. 80:67938g and 142556m (1974).
Armour Pharmaceutical Company
Moyer Donald B.
Mybeck Richard R.
LandOfFree
Purification of plasminogen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purification of plasminogen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purification of plasminogen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-833542